WinstonWınston
Back
Kimo logo

Kimo

KIMO
Winston Score
–
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.
Track this stock — start free trial

Winston Score History

The full picture

Kimo, Inc. is a small clinical-stage biopharmaceutical company focused on developing drugs to treat cancer. Its main work centers on a drug called upifitamab rilsodotin, which is designed to target certain types of ovarian cancer. The company's customers are ultimately cancer patients, and its products are aimed at oncologists and hospitals in the medical market.

Kimo makes no product revenue yet because its drugs are still being tested in clinical trials. The company is based in the United States and funds its operations through cash reserves and potential future partnerships or licensing deals. Its competitive position depends almost entirely on whether its lead drug candidate succeeds in clinical trials and earns approval from the FDA — if trials fail or approval is denied, the company faces serious financial risk since it has no other approved products generating income.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
no trend
Data not available
Profit after running costs
Operating Margin
N/A
no trend
Data not available
Return on the money invested
ROCE
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
no trend
Data not available
Profit growth
EPS YoY
N/A
no trend
Data not available
How steady the profit is
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
no trend
Data not available
Spare cash per sale
FCF Margin
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
no trend
Data not available
Covers its interest
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/A
no trend
Data not available
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial